INTRODUCTION: The 6-min walk test (6MWT) has prognostic value in various pulmonary
disorders including idiopathic pulmonary fibrosis (IPF). We determined the individual …

BACKGROUND AND AIM OF THE WORK: Idiopathic pulmonary fibrosis (IPF) is a
progressive disease with high mortality rates and a median survival of 2–3 years from time of …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with a median
survival of∼ 3 yrs. Measurements of airflow and lung volumes at rest are generally used to …

Rationale The response characteristics of the 6 minute walk test (6MWT) in studies of
idiopathic pulmonary fibrosis (IPF) are only poorly understood, and the change in walk …

The six-minute walk test (6MWT) is a simple test that is widely used to assess functional
exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). Patients with IPF have …

Rationale: The 6-minute-walk test (6MWT) is a practical and clinically meaningful measure
of exercise tolerance with favorable performance characteristics in various cardiac and …

Background The 6-minute walk test distance (6MWD) has been shown to be a valid and
responsive outcome measure in patients with idiopathic pulmonary fibrosis (IPF). The …

6-min walk distance (6MWD) has recently been shown to be associated with the risk of
mortality in patients with idiopathic pulmonary fibrosis (IPF); however, the independent …

BACKGROUND: Few studies have investigated the relationship between physiological
outcomes and quality of life in patients with idiopathic pulmonary fibrosis (IPF). Health …

Rationale and Hypothesis: Idiopathic pulmonary fibrosis is a fatal disease with a variable
rate of progression. We hypothesized that changes in distance walked and quantity of …